The traditional molecular classification of breast cancer includes luminal A, luminal B, HER2‐positive, and TNBC, with the prognosis for TNBC frequently being poor due to a limited availability of therapeutic targets [29, 30]. Here, ERBB2 is linked to breast cancer.